Vanguard Morningstar Mega Cap Growth ETF (MGK)
Live price chart, market sentiment, and community perspectives for Vanguard Morningstar Mega Cap Growth ETF (AMEX: MGK).
Live price chart, market sentiment, and community perspectives for Vanguard Morningstar Mega Cap Growth ETF (AMEX: MGK).
On our desk, we are closely tracking MGK's extreme weight concentration, where just five stocks—NVIDIA, Apple, Microsoft, Alphabet, and Amazon—comprise 46% of the fund's total weight. While this concentration drove its 28% past-year return outperforming the SandP 500, it also means a coordinated 20% drawdown in the top three names would immediately shave roughly 7% off the entire fund before factoring in any satellite holding shifts.
Looking at the quantitative profile, MGK carries a beta of 1.26 against a low 0.05% expense ratio, offering a very clean vehicle for long-term mega-cap exposure. However, historical performance metrics show it trails QQQ across multiple timeframes, such as returning 25% versus 35% over one year, and 465% versus 557% over a ten-year horizon.
In our strategy sessions, recent market volatility—such as the fund giving back over 6% in a single week—triggered heavy institutional buying. Allocators view these dips as prime entry points to capture high-growth characteristics, even as retail investors voice ongoing anxieties regarding potential AI-related valuation bubbles.
Comparing peer options like the Vanguard Russell 1000 Growth ETF (VONG), which spreads exposure across nearly 400 companies, MGK clearly opts for an aggressive, highly concentrated mega-cap strategy. Investors must weigh whether they prefer VONG's broader large-cap growth diversification or MGK's pure-play dominance in names like NVIDIA at 13.75% and Apple at 11.77%.
From a risk management standpoint, the heavy reliance on AI capital expenditures makes MGK particularly sensitive to hyperscaler return expectations. If AI monetization timelines disappoint, the heavy top-heavy distribution could rapidly accelerate downside momentum despite the diversification offered by non-tech sectors.
Explore plasma cleansing, somatic organ swaps, and BCI.